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a b s t r a c t
Dengue virus is responsible for 50–100 million new infections annually worldwide. The virus uses
error-prone RNA polymerase during genome replication in a host, resulting in the formation of closely
related viruses known as quasispecies. The availability of next-generation sequencing technology pro-
vides opportunities to analyze viral quasispecies. Before analysis, it is crucial to increase the amount
of DNA because of the limited amounts of viral genomic material that can be isolated from a patient.
However, using speciﬁc primers may overlook the occurrence of possible variations at primer binding
sites. To address this problem, the performance of two sequence-independent ampliﬁcation methods
was compared for whole genome ampliﬁcation (WGA): phi29 DNA polymerase-based WGA and wholeengue
hi29
hole transcriptome ampliﬁcation
mpliﬁcation bias
transcriptome ampliﬁcation (WTA). Both methods have the ability to provide complete coverage of the
dengue genome from template amounts as lowas 1ng. However,WTA showed greater efﬁciency in terms
of yield (WTA:∼10g; phi29-basedWGA:∼500ng) and lower ampliﬁcation bias. In conclusion, theWTA
ampliﬁcation kit was shown to perform substantially better than phi29 DNA polymerase-based WGA in
terms of both ﬁnal concentration and ampliﬁcation bias in amplifying small genomes, such as that of the
dengue virus.
201©
. IntroductionThe dengue virus is a mosquito-borne arbovirus with approx-
mately 11kb of positive-sense single-stranded RNA, and belongs
Abbreviations: WGA, whole genome ampliﬁcation; WTA, whole transcriptome
mpliﬁcation.
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to the family Flaviviridae, genus Flavivirus (Weaver and Vasilakis,
2009). It is transmitted to and from humans through Aedes
mosquitoes; the transmission of genetic variations has allowed
complete adaptation of the virus toAedes aegypti, and ismaintained
via an endemic/epidemic cycle in population centers throughout
the tropics (Tolle, 2009). Dengue virus infections can range from
asymptomatic undifferentiated fever to dengue fever (DF), and
even to dengue hemorrhagic fever (DHF). At present, there is no
effective vaccine or antiviral therapy available for dengue virus
infections, resulting in a global burden of 50–100 million cases
annually (Smart and Saﬁtri, 2009) with approximately 2.5 billion
people at risk of infection (World Health Organization, 2002). As an
RNA virus, dengue virus utilizes RNA polymerase, which is error-
prone due to a lack of proofreading activity. This has led to the
Open access under CC BY-NC-SA license.appearance of clusters of variant viruses, referred to as quasis-
pecies, during replication in the host. It is believed that dengue
quasispecies may play an important role in viral evolution and
adaptation, and may also be involved in the pathogenesis of the
license.
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Table 1
Sequence of primers used for generating DNA templates (two fragments set) and testing primer efﬁciency and ampliﬁcation bias.
Primer sets Number Direction Primer sequence Location Product size (bp)
Two fragments set
Fragment A
Forward agttgttagtctacgtggaccg 1–6709 6709
Reverse ccagtattattgaagctgctatcca
Fragment B
Forward ggatggtgagcattttagccagttc 4166–10,688 6523
Reverse tggcgttctgtgcctggaat
Testing primer set
P1
Forward agttgttagtctacgtggac 1–213 213
Reverse ctgcagcattccaagtgaga
P2
Forward catgtcttaggtcgcctgat 1972–2146 175
Reverse tctcaaacatttggccgata
P3
Forward ttgaagacaacccagagatcg 5036–5147 112
Reverse ctgactatggccggaaggta
P4
Forward agtggaagcaggacgaacac 8034–8181 148
Reverse ggctcctccatatttcctttg
P5
Forward tggatgacaacggaagaca 9976–10,255 250
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isease and/or drug resistance (Domingo et al., 2006; Eckerle et al.,
010; Zagordi et al., 2010).
Studies of viral quasispecies have increased rapidly due to the
vailabilityofnext-generation sequencing technology.A shortcom-
ng of this novel technology is its requirement for DNA templates in
arge quantities, which is problematic for clinical samples. Recent
tudies on thewhole genomeof dengue virus have generally ampli-
ed the genome prior to sequencing with PCR techniques and
peciﬁc primers (Chin-Inmanu et al., 2012; Christenbury et al.,
010; David et al., 2010; Osman et al., 2008). However, the vari-
tions existing in viral quasispecies can affect the efﬁciency of
rimers and also conceal the occurrence of site-speciﬁc variations
t the primer binding sites. The use of whole genome ampliﬁcation
WGA) technology has been proposed to overcome these limita-
ions, with its ability to produce a yield of one microgram of WGA
roduct from a template of only one nanogram. TwoWGAmethods
re of particular interest: The ﬁrst is PCR-based WGA, which uses
ither quasi-random, random, or degenerated primers for ampliﬁ-
ation. This method has been reported to be successfully applied
n the identiﬁcation of viruses (Banach et al., 2009; Djikeng et al.,
008), as well as in the ampliﬁcation of templates for the metage-
omic detection of viral pathogens (Nakamura et al., 2009). The
econd WGA method is based on bacteriophage phi29 DNA poly-
erase, which exhibits strand displacement activity. This method
ses random nucleotides—typically hexamers—as primers for
mpliﬁcation, and has been employed extensively for amplifying
ig. 1. Diagram of PCR products of 2 sets of primer designs for the dengue genome. The
et (Fragments A and B) was designed to copy the whole genome into 2 large fragments
P1–P6). The second set (P1–P6) was designed to measure the ampliﬁcation factor and am
he P1 product starts from the ﬁrst base of the dengue genome and the P6 product endsatggcatgtaatctgtgta
ctagtctcgctggaagg 10,562–10,688 127
cgttctgtgcctggaat
the human genome (Arriola et al., 2007; Barker et al., 2004; Bergen
et al., 2005; Berthet et al., 2008; Dean et al., 2002; Ling et al., 2009;
Pan et al., 2008).
In this study, these twomethodswereused to amplify thewhole
dengue viral genome in order to compare their ampliﬁcation efﬁ-
ciency, genomic coverage, and ampliﬁcation bias.
2. Material and methods
2.1. Dengue viral RNA preparation
Dengue virus serotype 2 (DENV2) strain 16681 was cultured
in a C6/36 cell line. The culture supernatant was extracted using
QIAamp® viral RNA mini kit (Qiagen, Hilden, Germany) according
to themanufacturer’s protocol. The extracted RNAwas quantitated
using NanoDrop ND-1000 Spectrophotometer (Thermo Scientiﬁc,
Wisconsin, United States) and stored at −70 ◦C until use.
2.2. Primers design
Two sets of primers were designed using Primer3 software
(Rozen and Skaletsky, 2000). FastPCR v.5.4.10 (Kalendar and
Schulman, 2009) and AutoDimer v.1 (Vallone and Butler, 2004)
were used to check for speciﬁcity and possible primer–dimer or
hairpin loop formation (Table 1 and Fig. 1). The ﬁrst set comprised
2 pairs of primers (Fragments A and B); these were designed to
whole genome of dengue virus serotype 2 strain 16681 is 10,688 bases. The ﬁrst
and serve as a template for testing primer efﬁciency of the second set of primers
pliﬁcation bias of phi29-based and random primer-based ampliﬁcation methods.
at the last base.
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mplify the dengue genome into 2 fragments, which were used as
emplates for thenext set of primers to test their efﬁciency. The sec-
nd set comprised 6 pairs of primers (P1–P6); these were designed
o verify ampliﬁcation efﬁciency and ampliﬁcation bias in different
arts of the dengue genome. Primers P1 and P6 were designed to
over the ﬁrst and last nucleotide of the DENV2 genome.
.3. cDNA synthesis
cDNA was synthesized using SuperScriptTM III reverse trans-
riptase (SSIII RT) (Invitrogen, CA, United States) according to the
anufacturer’s protocol, with some modiﬁcations (Berthet et al.,
008). The extracted viral RNA was mixed with 3′-end primer and
NTP mix. This RNA mixture was denatured at 65 ◦C for 5min and
ubsequently used in cDNAsynthesis bymixingwith 10×RTbuffer,
5mM MgCl2, 0.1M DTT, 40U/l of RNase OUT, and 200U/l of
SIII RT. The mixture was then incubated at 50 ◦C for 50 or 90min
nd 85 ◦C for 5min to terminate the reaction. The product was col-
ectedbybrief centrifugation and incubated at 37 ◦C for 20minwith
NaseH to remove remainingRNA. Theﬁrst-strand cDNA synthesis
roduct was stored at −20 ◦C or −70 ◦C.
.4. Preparation of templates for primer efﬁciency test
The viral cDNAwas ampliﬁed into two fragments using primers
or Fragments A and B. Four microliters of cDNA were mixed with
mpliﬁcation mix (2U of Accuprime Taq Polymerase High Fidelity,
0× Accuprime PCR buffer, 10M forward primer, 10M reverse
rimer, and DEPC-treated water) and ampliﬁed using PCR Thermal
ycler Biometra® T gradient in the following steps: initialization at
4 ◦C for 15 s, 40 cycles of denaturation (94 ◦C for 15 s), annealing
55 ◦C for 30 s) and extension (68 ◦C for 5 or 7min depending on
ragment size), and ﬁnal elongation at 68 ◦C for 10min before the
eactionwas cooledon ice. ThePCRproductswere run in1%agarose
el. The speciﬁc band of each PCR product was cut from the gel
nd extracted using QIAquick Gel Extraction Kit (QIAGEN, Hilden,
ermany).
.5. Bacteriophage phi29 DNA polymerase-based whole genome
mpliﬁcation
Illustra GenomiPhi V2 DNA Ampliﬁcation (GE Healthcare,
angkok, Thailand) is based on phi29 DNA polymerase, which is
esigned for DNA ampliﬁcation. In order to amplify dengue RNA
enome, we ﬁrst synthesized cDNA using SSIII RT as described
bove. Next, 1l of cDNA templatewas added to 9l of GenomiPhi
2 sample buffer, and denatured at 95 ◦C for 3min before cooling
mmediately in ice. The master mix of reaction buffer and enzyme
ix were then prepared and added to the prior mixture to a ﬁnal
olume of 20l. The reactions were incubated at 30 ◦C for 90min
nd then inactivated at 65 ◦C for 10min.
.6. Whole transcriptome ampliﬁcation
The TransPlex® Complete whole transcriptome ampliﬁcation
WTA) kit (Sigma–Aldrich, Bangkok, Thailand) is based on quasi-
andom primers and contains RT enzymes. Therefore, isolated RNA
an be used directly without a separate step for cDNA synthesis.
he procedure was started by preparing previously isolated RNA
1ng input) into the Library Synthesis Solution and incubated at
0 ◦C for 5min. The mixture was then added to the library synthe-
ismix, consisting of Library Synthesis Buffer and Library Synthesis
nzyme, and incubated in a thermal cycler with the following con-
itions: 18 ◦C for 10min, 25 ◦C for 10min, 37 ◦C for 30min, 42 ◦C
or 10min, and 70 ◦C for 20min. The ﬁnal ampliﬁcation step was
he addition of library synthesis composition with ampliﬁcational Methods 195 (2014) 141–147 143
mixture and incubation at 94 ◦C for 5min, followed by 70 cycles of
denaturation (94 ◦C for 1min) and annealing/extension (70 ◦C for
5min).
2.7. Puriﬁcation and quantitation of ampliﬁed DNA
After ampliﬁcation, the products were puriﬁed using QIAquick
PCR Puriﬁcation Kit according to the manufacturer’s instructions
(Qiagen, Hilden, Germany) and quantitated using a NanoDrop ND-
1000 spectrophotometer.
2.8. PCR ampliﬁcation to examine genomic coverage and
ampliﬁcation bias
Conventional PCR was performed using PCR Thermal Cycler
Biometra® T gradient. Twenty-ﬁvemicroliters of PCR reaction con-
tained the following: 62.5mM MgCl2, 5l of 5× GoTaq PCR buffer,
5mM dNTP, 10M forward primer, 10M reverse primer, 0.5U
of GoTaq DNA polymerase (Promega, Singapore), 1l of DNA tem-
plate, and topped up to the ﬁnal volume with DEPC-treated water.
The ampliﬁcation involved the following steps: initialization at
94 ◦C for 5min, 30 cycles of denaturation (94 ◦C for 1min), anneal-
ing (55 ◦C or 60 ◦C for 1min) and extension (72 ◦C for 30 s), and
ﬁnal elongation at 72 ◦C for 5min before the reaction was cooled
on ice. Each pair of speciﬁc primers was done in triplicate in the
experiment.
2.9. Real-time PCR
Real-time qPCR reactions were performed in 10l total volume
comprising 5l of 5× reaction mix SYBR green I (Roche, Bangkok,
Thailand), 5M forward primer, 5M reverse primer, and 0.4l
of template. The mixture was started at the denaturation step at
95 ◦C for 5min, followed by 45 cycles of 95 ◦C for 30 s, 58 ◦C for 30 s
and 72 ◦C for 30 s, with a melting curve of 60–90 ◦C and cooling of
the reaction at 40 ◦C in a LightCycler® II RealTime PCR instrument
(Roche, Bangkok, Thailand). The threshold cycles (CT) were gath-
ered from the sample for each pair of speciﬁc primers (triplicate).
The collected data were clariﬁed with a standard curve of known
amount of input DNA in the same experiment, and the ampliﬁca-
tionproducts of cDNA template andWGA-ampliﬁed reactionswere
compared in order to calculate ampliﬁcation fold.
2.10. Mixing of dengue RNA template and sequencing
To determine the efﬁcacy of the WTA methodology in pre-
serving the diversity of the ampliﬁed products, a simulation
analysis of dengue quasispecieswas performed. RNAof twodengue
genotypes—prototype strain (16681) and 16681 mu1 strain (mod-
iﬁed genotype of strain 16681)—weremixed in the followingmolar
ratios: 1:1, 1:3, and 1:7; and either converted to cDNA or ampliﬁed
directly using TransPlex WTA. All sequences were analyzed with
speciﬁc primers using the Sanger method, and a comparison of the
sequences before and after ampliﬁcation with TransPlex WTA was
conducted.
3. Results
3.1. Veriﬁcation for primer efﬁciency
Six primer pairs (P1–P6) were designed and used to amplify dif-
ferent parts of the dengue genome to check genomic coverage and
ampliﬁcation bias (Fig. 1). All 6 primer pairs were tested to investi-
gate ampliﬁcation bias. As it is difﬁcult to amplify the entire dengue
genome as a single fragment, the viral genome was ﬁrst ampli-
ﬁed into two similarly sized fragments (Fragments A and B). The
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Fig. 2. Primer efﬁciencies of the P1–P6 primer set. Real-time qPCR was performed
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ed from Fragment A and P3(2) from Fragment B. The cycle threshold was used to
ompare primer efﬁciencies. Experiments were done in triplicate.
wo fragments were 10-fold serial diluted and used as templates in
eal-time qPCR. The ampliﬁed product from each of the 6 primer
airs was monitored and analyzed for cycle threshold (CT) (Fig. 2).
ithin the same fragment, all primers had comparable CT. But at
ow amounts of template (50pg and 0.5ng), primers amplifying
ragment A had a slightly higher CT than those amplifying Frag-
ent B. P3primer,which could amplify products inboth fragments,
as also observed to have a similar pattern. At higher amounts of
emplate (5ng and 50ng), all primers gave comparable CT on all
ragment templates.
ig. 3. Real-time qPCR of products from phi29-based whole genome ampliﬁcation. The
eriod of 50min (white bar) and 90min (black bar). Ten-fold serial dilutions of cDNA t
ubsequently used as templates for the P1–P6 primer set and measured by real-time q
ormula: Amplication fold = (concentrationof product× reactionvolume)/total amount ofal Methods 195 (2014) 141–147
3.2. Optimal time for cDNA synthesis for phi29-based whole
genome ampliﬁcation
A conversion of RNA to cDNA is required for phi29-based WGA.
Equal amountsofRNAwereconverted into cDNAusingSSIII RTwith
incubation periods of 50 or 90min. The cDNA was then ampliﬁed
by GenomiPhi V2 DNA ampliﬁcation (GV2). Incubating for 90min
during cDNA synthesis resulted in lower CT, indicating higher yield
from every primer set in every template concentration (Fig. 3A).
Increasing the incubation period to 180min did not increase the
ﬁnal yield (data not shown).
3.3. phi29-based whole genome ampliﬁcation
The ampliﬁcation fold analysis showed that GV2 ampliﬁcation
at 1ng of template gave good genome coverage (Fig. 3B). The total
product yield of GV2 from 1ng of template was 512.5±20.2ng but
the products were not evenly distributed. There were more prod-
ucts generated in the inner part of the genome (covered by primers
P2–P5). The least amount of product was found at the 3′ end of the
dengue genome,where the product yield from1ngof templatewas
able to produce only a faint smeared band on gel electrophoresis.
GV2 ampliﬁcation of 20ng of template was conducted and the gel
electrophoresis showed a smear bandmainly in the range between
6557bpand longer than23,130bp (Fig. 4A, left). To conﬁrmthat the
starting cDNA template was synthesized with a reverse transcription incubation
emplates were ampliﬁed by GenomiPhi V2. The products of GenomiPhi V2 were
PCR (A). Ampliﬁcation folds per reaction (B) were calculated using the following
template.
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2 with a negative control (right) and (B) TransPlex WTA. The ampliﬁed products w
eaction (D) were calculated using the following formula: Amplication fold = (conce
mear band of GV2 product was from the dengue genome and not
ue to host genome contamination, the ampliﬁed negative control
f culture serum was prepared and is shown in Fig. 4A (right).
.4. Random primer-based whole genome ampliﬁcation
Because GV2 gave good genome coverage at 1ng of tem-
late, TransPlex WTA platform was compared at the same
mount. The total product yield of WTA for 1ng of template was
0,452.6±1487.8ng. The gel electrophoresis of products showed
smear band mainly in the range between 100bp and 700bp
Fig. 4B). There was ampliﬁcation in all parts of the genome; WTA
ad lower CT, indicating higher amounts of products from primers
1–P5 (Fig. 4C). The 5′ end covered by P6 had comparable CT in
oth methods. The ampliﬁcation fold of WTA was higher and ﬂuc-
uated less than that of GV2. The reaction volumes were 75l for
TA and 20l for GV2, indicating that the ampliﬁcation fold of the
6 region of WTA was approximately 4 times higher despite the
imilar CT (Fig. 4D).
To investigate the potential application of TransPlex WTA as a
ool to study quasispecies, a simulation analysis was conducted in
hich two known genotypes of dengue virus were mixed in dif-
erent ratios (Fig. 5). The arrow indicates the site of mutation (G
or 16681 and A for 16681 mu1). The ﬁndings showed an expected
esult of gradually decreasing peaks at the site of mutation in the
ifferent ratios of mixed viruses. By comparing pre-ampliﬁcation
nd post-WTA ampliﬁcation products, the results were observed
o have a similar pattern, showing that the WTA methodology was
ble to generally preserve the diversity of the ampliﬁed products.
his suggests thatWTA can be efﬁciently used in observing quasis-
ecies in a viral population.
To conﬁrm that WTA can be used in clinical samples, dengue
irus serotypes 1 and 3 were isolated from patients and analyzed.methods. The typical patterns of gel electrophoresiswere shown for (A)GenomiPhi
easured by real-time qPCR using the P1–P6 primer set (C). Ampliﬁcation folds per
on of product× reaction volume)/total amount of template.
The ampliﬁcation product of WTA appeared as a smear band
(100–400bp) of patient sample ampliﬁed product (Fig. S3: Left,
sample from patient with dengue virus serotype 1 infection; Right,
sample from patient with dengue virus serotype 3 infection).
4. Discussion
Dengue virus quasispecies may play an important role in viral
adaptation and pathogenesis. The identiﬁcation of these quasis-
pecies is difﬁcult and time consuming (Kurosu, 2011). Two novel
methods have been introduced for DNA template preparation for
robust next-generation sequencing: phi29 DNA polymerase-based
WGA and WTA. In this study, these two methods were compared
in their preparation of dengue viral genome as candidate methods
with high coverage and low ampliﬁcation bias that would allow for
the accurate identiﬁcation of viral variants. First, a primer set was
designed to amplify the dengue genome into two amplicons, which
provide a more efﬁcient way for template preparation.
To facilitate cDNA production for the whole dengue viral
genome, the optimal incubation time at the cDNA synthesis step
was determined; a set of 6 primer pairs for the whole genome (in
the 5′–3′ direction) was applied to the templates produced from
the ﬁrst primer set in order to evaluate coverage and ampliﬁcation
bias. The total band densities of the 6 primer pairs when applied
to 90-min RT cDNA appeared slightly higher than those from 50-
min RT cDNA (Fig. 3). In addition, the PCR product from primer P1
(targeting the 5′ end of the dengue genome) on 90-min RT cDNA
was observed to be higher than that of 50-min RT cDNA. This sug-
gests that with the 6 primer pairs, cDNA from 90-min RT wasmore
complete in size and higher in template concentration than cDNA
from 50-min RT. Although there were differences between the size
and concentrationof products of eachprimerpair, thesedifferences
may also be due to the individual conditions of the PCR process.
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Fig. 5. Determining ampliﬁcation efﬁciencies of TransPlexWTA usingmixed genotypes of dengue serotype 2. Two different dengue serotype 2 genotypes—prototype (16681)
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tnd mutant (16681 mu1) strain—were mixed in the following molar ratios: 1:1 (A)
efore being ampliﬁed with TransPlex WTA, and the right panel shows the results a
he PCR processwas conducted againwith an extended incubation
ime for cDNA synthesis at 180min, and the results were assayed
sing test primers. No improvements were observed in PCR prod-
cts from the 180-min RT cDNA template over those of the 90-min
T (data not shown).
To test the efﬁciency of the 6 primer pairs, the dengue genome
as ampliﬁed into 2 fragments of 6709 and 6503bp in length, and
erial diluted to use as templates for the 6 primer pairs. The results
n Fig. 2 show similar patterns for each primer pair at different
emplate concentrations. These ﬁndings suggest no differences in
fﬁciency among the primer pairs.
After testing primer efﬁciency and conditions for the RT pro-
ess, the GV2 platformwas applied to the viral cDNA. In Fig. 4A, gel
lectrophoresis showed the size of GV2 product from 20ng dengue
enome template. The smear band was observed to be in the range
etween 6557bp and over 23,130bp, suggesting the possible for-
ation of a hyperbranched structure of GV2 product (Lage et al.,
003). The results (negative control; Fig. 4A, right) conﬁrmed that
his bandwasnotdue to contamination fromthehost genome.Con-
itions were optimized (Fig. 3), and the results showed an increase
n the ampliﬁed product using the GV2 platform in both 50- and
0-min RT. Also, the amount of product of primer P1 from 90-min
T cDNA was observed to be slightly higher than those from 50-
in RT cDNA. However, it should be noted that there was a lower
mount of the ampliﬁed PCR product from primers at either end
5′ or 3′ end) of the dengue genome using the GV2 kit, regardless of
hether 50min or 90min were used. This observation may be due
o both randomhexamer primers used in the GV2 platform and the), and 1:7 (C). The left panel shows the sequencing results of the mixed genotypes
mpliﬁcation with TransPlex WTA.
linear cDNAof thedenguegenome itself. These randomprimers can
bind randomly along the genome, and may lead to higher product
yields from within the genome than at either end. The GV2 plat-
form uses phi29 DNA polymerase, which may be more effective
for a circular DNA format (Dean et al., 2001). Because the dengue
genome is small and linear, the phi29 DNA polymerase may not be
as effective in this application (especially at low concentrations)
as it was originally developed to amplify the human genome (Pan
et al., 2008).
To conﬁrm the results, ampliﬁcation bias was adjusted for after
amplifying cDNA with GV2 platform using real-time qPCR. The
results are presented as CT in Fig. 3A. The bias was observed
in the same pattern in every template concentration, suggesting
that it may be intrinsically difﬁcult to amplify some parts of the
genome, especially from primer pairs targeting either end of the
genome. By calculating the fold difference between unampliﬁed
cDNA and GV2-ampliﬁed products, the increase after ampliﬁca-
tion was observed to range from 1.0 to 529.0 folds for each primer
set from the 90-min RT process with cDNA template at 1ng/l
concentration (Figs. 3B and 4D), as shown by the 512.5±20.2ng
total yield of DNA. There was a similar pattern calculated from
both unampliﬁed and GV2-ampliﬁed 90-min RT cDNA template in
semi-quantitative PCR (Fig. S1).
After ampliﬁcation bias from the GV2-ampliﬁed product was
examined, the TransPlex WTA kit was introduced to amplify the
RNA of dengue virus from 1ng input. The size of the WTA prod-
uct was observed to range from 100 to 700bp (Fig. 4B). The fold
changes between RNA template and WTA products were also
rologic
m
w
t
w
t
P
p
t
(
t
s
a
ﬁ
w
p
c
T
f
m
t
e
t
1
t
i
t
p
ﬁ
g
t
a
h
o
A
f
w
t
J
t
o
P
i
r
i
a
I
A
i
2
R
A
World Health Organization, 2002. Dengue and dengue hemorrhagic fever, Geneva,P. Sujayanont et al. / Journal of Vi
onitored, and observed to be higher in amount with less bias
hen compared with GV2-ampliﬁed product of 90-min RT cDNA
emplate at 1ng concentration (WTA: 18.8–13,928.6; Fig. 4D),
hich corresponded to 10,452.6±1487.8ng ofDNAextracted from
he WTA product. The result was conﬁrmed by semi-quantitative
CR (Fig. S2), which showed similar patterns for all primers except
rimerP1. Thisprimer showeda folddifferenceof100,000,whereas
he qPCR result showed only a 4727.3±1073.2 fold difference
Fig. 4D).
Todetermine theefﬁcacyof theWTAmethodology inpreserving
he diversity of the ampliﬁed products, two genotypes of dengue
erotype 2 were mixed in various ratios, and their sequences
nalyzed using the Sanger method (Fig. 5). Sequencing results con-
rmed that WTA was able to efﬁciently amplify mixed genotypes
hile conserving thediversityof theproductswhencomparedwith
re-ampliﬁcation product. The peak at the site of mutation also
hanged gradually according to the ratios of the serotype mixture.
hese observations suggest that TransPlex WTA has applications
or analyzing quasispecies in viral populations. To ensure that this
ethodology can be applied to clinical samples, which are thought
o contain quasispecies, the specimens of 7 patients infected with
ither dengue serotypes 1 or 3 were tested (Fig. S3). Gel elec-
rophoresis showedsmearbandsofWTAproductswith the rangeof
00–400bp. The results suggest thatWTAcanbeusedwith samples
hat are believed to contain a population of closely related viruses
solated from patients.
In conclusion, the TransPlex WTA ampliﬁcation kit was shown
o have remarkably better performance when compared with a
hi29 DNA polymerase-based WGA platform in terms of both
nal concentration and ampliﬁcation bias in amplifying a small
enome, such as that of the dengue virus. These ﬁndings can con-
ribute to future studies that use this ampliﬁcation technique for
mplifying RNA genomes—especially those with a small size—and
ave further applications in next-generation sequencing technol-
gy.
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